Nitric oxide preconditioning regulates endothelial monolayer integrity via the heat shock protein 90-soluble guanylate cyclase pathway
Open Access
- 1 February 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 292 (2) , H893-H903
- https://doi.org/10.1152/ajpheart.00498.2006
Abstract
Large (pathological) amounts of nitric oxide (NO) induce cell injury, whereas low (physiological) NO concentrations often ameliorate cell injury. We tested the hypotheses that pretreatment of endothelial cells with low concentrations of NO (preconditioning) would prevent injury induced by high NO concentrations. Apoptosis, induced in bovine aortic endothelial cells (BAECs) by exposing them to either 4 mM sodium nitroprusside (SNP) or 0.5 mM N-(2-aminoethyl)- N-(2-hydroxy-2-nitrosohydrazino)-1,2-ethylenediamine (spermine NONOate) for 8 h, was abolished by 24-h pretreatment with either 100 μM SNP, 10 μM spermine NONOate, or 100 μM 8-bromo-cGMP (8-Br-cGMP). Repair of BAECs following wounding, measured as the recovery rate of transendothelial electrical resistance, was delayed by 8-h exposure to 4 mM SNP, and this delay was significantly attenuated by 24-h pretreatment with 100 μM SNP. NO preconditioning produced increased association and expression of soluble guanyl cyclase (sGC) and heat shock protein 90 (HSP90). The protective effect of NO preconditioning, but not the injurious effect of 4 mM SNP, was abolished by either a sGC activity inhibitor 1H-[1,2,4]oxadiazolo-[4,3- a]quinoxalin-1-one (ODQ) or a HSP90 binding inhibitor (radicicol) and was mimicked by 8-Br-cGMP. We conclude that preconditioning with a low dose of NO donor accelerates repair and maintains endothelial integrity via a mechanism that includes the HSP90/sGC pathway. HSP90/sGC may thus play a role in the protective effects of NO-generating drugs from injurious stimuli.Keywords
This publication has 48 references indexed in Scilit:
- Hsp90 inhibitors: Small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradationMedicinal Research Reviews, 2005
- Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and δ1-opioid receptor agonists is mediated by iNOSAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Systemic Endothelial Dysfunction as an Early Predictor of Adverse Outcome in Heart FailureArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Nitric oxide priming protects nitric oxide-mediated apoptosis via HEME OXYGENASE-1 inductionFree Radical Biology & Medicine, 2003
- Hsp90 and Caveolin Are Key Targets for the Proangiogenic Nitric Oxide–Mediated Effects of StatinsCirculation Research, 2001
- Molecular aspects of soluble guanylyl cyclase regulationGeneral Pharmacology: The Vascular System, 2000
- Nitric oxide–an endothelial cell survival factorCell Death & Differentiation, 1999
- I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1999
- The nitric oxide hypothesis of late preconditioningBasic Research in Cardiology, 1998
- Dynamic activation of endothelial nitric oxide synthase by Hsp90Nature, 1998